| scholarly article | Q13442814 |
| P2093 | author name string | M A Cohen | |
| S R Bloom | |||
| M A Ghatei | |||
| M Patterson | |||
| G S Frost | |||
| R L Batterham | |||
| A J Park | |||
| C W Le Roux | |||
| S M Ellis | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | appetite | Q28578 |
| P304 | page(s) | 3989-92 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Pancreatic polypeptide reduces appetite and food intake in humans | |
| P478 | volume | 88 |
| Q61795694 | A Plant-Based Meal Increases Gastrointestinal Hormones and Satiety More Than an Energy- and Macronutrient-Matched Processed-Meat Meal in T2D, Obese, and Healthy Men: A Three-Group Randomized Crossover Study |
| Q47582484 | Altered Appetite-Mediating Hormone Concentrations Precede Compensatory Overeating After Severe, Short-Term Energy Deprivation in Healthy Adults |
| Q26779389 | Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence? |
| Q41491222 | An enriched, cereal-based bread affects appetite ratings and glycemic, insulinemic, and gastrointestinal hormone responses in healthy adults in a randomized, controlled trial. |
| Q37225021 | Anorexia of aging and gut hormones. |
| Q37996099 | Anti-obesity drugs: a review about their effects and their safety |
| Q61812165 | Appetite Perceptions, Gastrointestinal Symptoms, Ghrelin, Peptide YY and State Anxiety Are Disturbed in Adolescent Females with Anorexia Nervosa and Only Partially Restored with Short-Term Refeeding |
| Q37811559 | Appetite and Hedonism: Gut Hormones and the Brain |
| Q35825708 | Appetite regulation and weight control: the role of gut hormones |
| Q33841063 | Appetite-regulating hormones in early life and relationships with type of feeding and body composition in healthy term infants |
| Q37960073 | Approaches to the pharmacological treatment of obesity |
| Q91600065 | Association between gene polymorphisms and obesity and physical fitness in Korean children |
| Q38380271 | Bariatric embolization of the gastric arteries for the treatment of obesity |
| Q35677192 | Bariatric surgery for extreme adolescent obesity: indications, outcomes, and physiologic effects on the gut-brain axis |
| Q38234236 | Benefit-risk assessment of orlistat in the treatment of obesity |
| Q39674955 | Beyond expectations: the physiological basis of sensory enhancement of satiety. |
| Q37508420 | Bowels control brain: gut hormones and obesity |
| Q37768338 | Bowels control brain: gut hormones and obesity |
| Q49501526 | C-terminal motif of human neuropeptide Y4 receptor determines internalization and arrestin recruitment |
| Q48065545 | Can Bayliss and Starling gut hormones cure a worldwide pandemic? |
| Q36849071 | Canine obesity: an overview |
| Q24601868 | Central and Peripheral Administration of Secretin Inhibits Food Intake in Mice through the Activation of the Melanocortin System |
| Q39145315 | Central and peripheral control of food intake. |
| Q30388865 | Central and peripheral molecular targets for antiobesity pharmacotherapy |
| Q33711005 | Cephalic phase pancreatic polypeptide responses to liquid and solid stimuli in humans |
| Q35751321 | Changes in Metabolic Hormones in Malaysian Young Adults following Helicobacter pylori Eradication |
| Q48526857 | Characterization of the neuropeptide Y system in the frog Silurana tropicalis (Pipidae): three peptides and six receptor subtypes. |
| Q64921605 | Copy number determination of the gene for the human pancreatic polypeptide receptor NPY4R using read depth analysis and droplet digital PCR. |
| Q52330980 | Copy number of pancreatic polypeptide receptor gene NPY4R correlates with body mass index and waist circumference. |
| Q33521218 | Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice |
| Q30399390 | Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity |
| Q35585206 | Cytotoxic helix-rich oligomer formation by melittin and pancreatic polypeptide |
| Q44945151 | Degradation Paradigm of the Gut Hormone, Pancreatic Polypeptide, by Hepatic and Renal Peptidases |
| Q36550618 | Design and synthesis of (ant)-agonists that alter appetite and adiposity |
| Q34691674 | Determination of affinity and activity of ligands at the human neuropeptide Y Y4 receptor by flow cytometry and aequorin luminescence |
| Q90577044 | Dietary berries, insulin resistance and type 2 diabetes: an overview of human feeding trials |
| Q47414237 | Dietary whey protein influences plasma satiety-related hormones and plasma amino acids in normal-weight adult women |
| Q34184127 | Differential acute postprandial effects of processed meat and isocaloric vegan meals on the gastrointestinal hormone response in subjects suffering from type 2 diabetes and healthy controls: a randomized crossover study |
| Q51898125 | Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. |
| Q46448409 | Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes |
| Q23761087 | Elevated ghrelin predicts food intake during experimental sleep restriction |
| Q37494328 | Emerging drugs for obesity therapy. |
| Q37906676 | Energy availability in athletes |
| Q33770382 | Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY. |
| Q39029575 | Epigenetic control of β-cell function and failure |
| Q58066161 | Evolution of the neuropeptide Y family: New genes by chromosome duplications in early vertebrates and in teleost fishes |
| Q39678448 | Expression of genes involved in energy homeostasis in the duodenum and liver of Holstein-Friesian and Jersey cows and their F(1) hybrid |
| Q46584956 | Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid |
| Q41248445 | Fungal endophytes associated with Viola odorata Linn. as bioresource for pancreatic lipase inhibitors |
| Q43288793 | Gastrointestinal hormones in food intake control |
| Q24669951 | Gastrointestinal hormones regulating appetite |
| Q37961090 | Gastrointestinal hormones: the regulation of appetite and the anorexia of ageing. |
| Q37047199 | Gastrointestinal peptides controlling body weight homeostasis. |
| Q35251043 | Gastrointestinal regulation of food intake |
| Q37366378 | Gastrointestinal satiety signals |
| Q35739940 | Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide |
| Q37322218 | Genome-wide association study suggested copy number variation may be associated with body mass index in the Chinese population |
| Q36993604 | Ghrelin and feedback systems |
| Q81787195 | Ghrelin increases food intake in obese as well as lean subjects |
| Q47174979 | Glucagon-like peptide 1 and pancreatic polypeptide responses to feeding in normal weight and overweight children |
| Q39111395 | Gut Microbiota in Obesity and Undernutrition |
| Q47356520 | Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters |
| Q28278826 | Gut hormones and the regulation of energy homeostasis |
| Q37057996 | Gut hormones as potential new targets for appetite regulation and the treatment of obesity |
| Q36452530 | Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism |
| Q35796674 | Gut hormones in the control of appetite |
| Q36468102 | Gut hormones: the future of obesity treatment? |
| Q36149033 | Gut peptide hormones: importance for food intake. |
| Q36455914 | Gut peptides and the regulation of appetite. |
| Q51302760 | Gut satiety hormones and hyperemesis gravidarum. |
| Q35667150 | Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy |
| Q42709946 | High molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice |
| Q93090672 | Human beta cells generated from pluripotent stem cells or cellular reprogramming for curing diabetes |
| Q37494269 | Hypothalamic regulation of food intake and clinical therapeutic applications |
| Q33736640 | Hypoxia-Related Hormonal Appetite Modulation in Humans during Rest and Exercise: Mini Review. |
| Q36470060 | Impact of Exercise Timing on Appetite Regulation in Individuals with Type 2 Diabetes |
| Q36856388 | In search of fat profits |
| Q51064780 | Independent and combined effects of eating rate and energy density on energy intake, appetite, and gut hormones. |
| Q47303576 | Insulin, glucose, and pancreatic polypeptide responses to a test meal in restricting type anorexia nervosa before and after weight restoration |
| Q97643489 | Integrating the inputs that shape pancreatic islet hormone release |
| Q40014796 | Integrative role of brain and hypothalamus in the control of energy balance |
| Q35586055 | Interactions between obesity-related copy number variants and dietary behaviors in childhood obesity |
| Q34078110 | Interactions of gastrointestinal peptides: ghrelin and its anorexigenic antagonists |
| Q98305996 | Investigating data-driven biological subtypes of sychiatric disorders using specification-curve analysis |
| Q22337035 | Is there a fatty acid taste? |
| Q43902544 | Ketosis and appetite-mediating nutrients and hormones after weight loss. |
| Q37365646 | Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide: interventional studies in humans |
| Q38125104 | Lifestyle intervention in childhood obesity: changes and challenges |
| Q61068502 | Low-dose pancreatic polypeptide inhibits food intake in man |
| Q47288853 | Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects |
| Q49138045 | Mass spectrometry-assisted confirmation of the inability of dipeptidyl peptidase-4 to cleave goldfish peptide YY(1-36) and the lack of anorexigenic effects of peptide YY(3-36) in goldfish (Carassius auratus). |
| Q47410306 | Meal size can be decreased in obese subjects through pharmacological acceleration of gastric emptying (The OBERYTH trial) |
| Q26865399 | Mechanisms of Weight Regain following Weight Loss |
| Q37125932 | Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. |
| Q37670545 | Mechanisms of weight loss after gastric bypass and gastric banding |
| Q37594773 | Modulation of neuropeptide Y receptors for the treatment of obesity |
| Q36490110 | Molecular mechanisms of appetite regulation |
| Q35130522 | NPY receptors as potential targets for anti-obesity drug development |
| Q33569276 | Neuroactive peptides as putative mediators of antiepileptic ketogenic diets |
| Q37352232 | Neuroendocrine and physiological regulation of intake with particular reference to domesticated ruminant animals |
| Q37991003 | Neuroendocrine control of metabolism |
| Q38185643 | Neuroendocrinology of obesity |
| Q36451817 | Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. |
| Q30429816 | New advances in models and strategies for developing anti-obesity drugs |
| Q38397535 | New molecular targets in the pathophysiology of obesity and available treatment options under investigation |
| Q58777536 | No Guts, No Loss: Toward the Ideal Treatment for Obesity in the Twenty-First Century |
| Q61068501 | No evidence of an additive inhibitory feeding effect following PP and PYY3−36 administration |
| Q38035293 | Obesity and appetite control |
| Q80356247 | Obesity and gastrointestinal sensory-motor function |
| Q33827988 | Obesity pharmacotherapy: what is next? |
| Q33607971 | Obesity treatment: novel peripheral targets |
| Q37511828 | Obesity, gut hormones, and bariatric surgery. |
| Q38514840 | Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones |
| Q51998590 | PYY in the expanding pancreatic epithelium. |
| Q57978507 | PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans |
| Q45716976 | PYY3-36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in mice |
| Q47337265 | Pancreatic polypeptide in obese children before and after weight loss. |
| Q26766485 | Pancreatic regulation of glucose homeostasis |
| Q35140241 | Pancreatic signals controlling food intake; insulin, glucagon and amylin |
| Q42569689 | Pathologic pancreatic endocrine cell hyperplasia |
| Q37734840 | Peptides and food intake. |
| Q35760298 | Peptides and their potential role in the treatment of diabetes and obesity |
| Q89977731 | Peptides from Natural or Rationally Designed Sources Can Be Used in Overweight, Obesity, and Type 2 Diabetes Therapies |
| Q38061797 | Peripheral signalling involved in energy homeostasis control |
| Q36753785 | Peripheral tissue-brain interactions in the regulation of food intake |
| Q35718588 | Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420. |
| Q51773475 | Plasma pancreatic polypeptide levels are associated with differences in body fat distribution in human subjects. |
| Q33919544 | Position and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues |
| Q61813066 | Postprandial Effects of Blueberry () Consumption on Glucose Metabolism, Gastrointestinal Hormone Response, and Perceived Appetite in Healthy Adults: A Randomized, Placebo-Controlled Crossover Trial |
| Q41625381 | Potential Hormone Mechanisms of Bariatric Surgery. |
| Q51768767 | Recent advances in clinical application of gut hormones. |
| Q38227248 | Recent advances in the regulation of pancreatic secretion |
| Q30403705 | Regulation of appetite to treat obesity |
| Q92826783 | Role of Peptide Hormones in the Adaptation to Altered Dietary Protein Intake |
| Q34582675 | Role of cholecystokinin in anorexia induction following oral exposure to the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol |
| Q35766237 | Role of gastrointestinal hormones in feeding behavior and obesity treatment |
| Q37791896 | Roles of Hormones in Taste Signaling |
| Q37347574 | Serum proteomic profiling of major depressive disorder |
| Q37171524 | Short-term aerobic exercise training increases postprandial pancreatic polypeptide but not peptide YY concentrations in obese individuals |
| Q57249773 | Single nucleotide polymorphisms in the neuropeptide Y2 receptor (NPY2R) gene and association with severe obesity in French white subjects |
| Q41689669 | Systematic single-cell analysis provides new insights into heterogeneity and plasticity of the pancreas. |
| Q90533544 | The Gut-Brain Axis, the Human Gut Microbiota and Their Integration in the Development of Obesity |
| Q58316252 | The Pathobiology of Diabetes Mellitus |
| Q89623082 | The Role of Protein and Free Amino Acids on Intake, Metabolism, and Gut Microbiome: A Comparison Between Breast-Fed and Formula-Fed Rhesus Monkey Infants |
| Q41883921 | The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study |
| Q35564373 | The effect of hydro-alcoholic extract of Artemisia absinthium on appetite in male rats |
| Q37095586 | The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones |
| Q36331824 | The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study. |
| Q91644302 | The effects of high intensity interval training on appetite management in individuals with type 2 diabetes: influenced by participants weight |
| Q62764228 | The effects of pancreatic polypeptide on locomotor activity and food intake in mice |
| Q36111183 | The evolution of neuroendocrine peptides |
| Q30357431 | The future role of gut hormones in the treatment of obesity |
| Q21296779 | The gut hormones in appetite regulation |
| Q35535513 | The gut sensor as regulator of body weight |
| Q36550610 | The hypothalamus, hormones, and hunger: alterations in human obesity and illness |
| Q34578590 | The obesity pipeline: current strategies in the development of anti-obesity drugs |
| Q30399340 | The pharmacological treatment and management of obesity |
| Q38019805 | The regulation of food intake by the gut-brain axis: implications for obesity |
| Q33941355 | The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes |
| Q38087696 | Treating the obese diabetic. |
| Q47191631 | Why Weight Loss Maintenance Is Difficult |
Search more.